Synthesis, Characterization and Biological Evaluation of Anticancer drug

Cancer chemotherapy celebrated its fiftieth anniversary in 1995. It was in 1945 that wartime research on the nitrogen mustards, which uncovered their potential use in the treatment of leukaemias and other cancers, was first made public. Cisplatin caused regression in a number of transplanted rodent tumours created no great excitement amongst chemotherapists. It was only later when it was tested clinically against ovarian cancer that results were sufficiently positive to encourage others to investigate. The way forward is to carry out extensive phase I and II clinical trials of the many new types of anticancer agent that have become available as a result of increased knowledge about cancer cells and how they differ from normal tissues.

Autorentext

Dr. Richa Kothari is currently Professor & Dean, School of Sciences in ITM University, Gwalior. She is also Head, School of Pharmacy, Dept. of Chemistry and Environmental Science, ITM University. She has completed three major research projects funded by DRDE, Gwalior, MPCST, Bhopal and MP Biotechnology Council. She has 07 patients to her credit.